RegenXBio's total assets for Q2 2025 were $581.03M, an increase of 18.35% from the previous quarter. RGNX total liabilities were $367.35M for the fiscal quarter, a 69.49% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.